- Home
- LI vs PEN Comparison
LI vs PEN Comparison
Compare LI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | PEN |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.6B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LI | PEN |
|---|---|---|
| Price | $10.90 | $317.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 26 | 16 |
| Target Price | $15.65 | ★ $361.83 |
| AVG Volume (30 Days) | ★ 2.8M | 330.7K |
| Earning Date | 11-25-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 1.70 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | N/A | $13.48 |
| Revenue Next Year | $25.64 | $12.98 |
| P/E Ratio | ★ $29.50 | $187.06 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $11.09 | $221.26 |
| 52 Week High | $24.89 | $362.41 |
Technical Indicators
Market Signals| Indicator | LI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 44.08 |
| Support Level | N/A | $315.60 |
| Resistance Level | $12.56 | $320.08 |
| Average True Range (ATR) | 0.25 | 1.72 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 9.24 | 55.98 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.